Elanco Unveils Its 2024 Impact Report
Greenfield, Ind. - On June 26, 2025, Elanco Animal Health Incorporated (NYSE: ELAN) proudly announced the release of its 2024 Impact Report. This comprehensive report highlights the company's ongoing efforts to improve animal care, directly benefiting not only the animals but also the people who care for them. The report introduces an innovative framework that revolves around four key communities of impact, celebrating Elanco’s ethos of 'Going Beyond' for animals, customers, society, and its dedicated workforce.
A Framework for Meaningful Change
In its latest approach to impact reporting, Elanco emphasizes its commitment to making a lasting, positive difference. The report delineates eight core ambitions that are pivotal to Elanco’s mission, aiming to create significant impacts within the communities it serves across the globe. Jeff Simmons, President and CEO of Elanco, stated, "We are dedicated to delivering positive impact through our daily efforts, providing innovative solutions to veterinarians, farmers, and pet owners. We are excited to introduce a new framework that integrates our purpose into every facet of our operations, fostering growth, accountability, and societal change."
Highlights of the Report
Going Beyond for Animals
Elanco’s dedication to animal health drives its numerous innovations that enrich the lives of pets and livestock alike.
- - The company successfully brought key products like Zenrelia, Credelio Quattro, and Pradalex to the market, generating $461 million in revenue in 2024, surpassing their target of $420 million to $450 million.
- - Elanco has significantly improved pet owners’ access to parasite protection, becoming the top retail parasiticide provider in the U.S. and launching the Pet Protect line, a new range of veterinary-formulated supplements.
- - In a commendable display of corporate responsibility, more than $400,000 worth of products were donated through partnerships aimed at promoting animal health and welfare.
- - Furthermore, Elanco became a signatory to the U.S. Animal Research Openness Agreement (USARO), underscoring its commitment to transparency in animal research practices.
Advocating for Customers
Elanco’s promise extends beyond animal care, emphasizing the importance of customer advocacy and problem-solving.
- - The launch of Bovaer®, a groundbreaking methane-reducing feed additive for dairy cattle, highlights their efforts to promote sustainability in livestock farming.
- - The FDA has granted approvals for new combination clearances for Elanco's product, Experior, enhancing its standing in livestock sustainability.
- - Through its UpLook database, Elanco has enrolled 11% of the U.S. dairy herd, allowing farmers to monetize carbon reduction credits, ultimately providing around $10 million in net returns.
- - The company also committed $310,000 in scholarships aimed at advancing education in veterinary science and animal health.
Commitment to Society
With a firm commitment to improving public health through animal welfare, Elanco's initiatives reflect its broader societal responsibilities.
- - Through the Elanco Food Safety Programme, nearly 150 global producers received crucial training to address Salmonella outbreaks in poultry.
- - Elanco employees contributed over 730 volunteer hours in food banks, helping to pack over 115,000 meals.
- - The company has also recovered over $7 million in counterfeit products and eliminated 700,000 dubious online advertisements since 2021.
- - In a strategic alliance with Medgene, Elanco is leveraging innovative vaccine technologies to combat infectious diseases in cattle.
Supporting Their People
Elanco’s commitment to its employees is illustrated through its supportive and empowering workplace culture.
- - The company reported a 71% Employee Engagement Score, reflecting a 4% increase from the previous year.
- - Employees contributed over 26,000 hours of volunteer work, equating to $870,000 in value across 1,100 organizations.
- - An innovative safety campaign has effectively reduced workplace accidents and enhanced employee wellness initiatives.
- - Further, the Kiel facility has achieved remarkable energy efficiency, powered entirely by renewable sources, showcasing Elanco's commitment to sustainability.
Conclusion
Elanco urges stakeholders and the general public to dive into the complete 2024 Impact Report and join them in their journey toward improving the lives of animals, customers, society, and their workforce. Their focus on creating meaningful impact reinforces their mission of making life better for all.
About Elanco
Elanco Animal Health Incorporated is a pioneer in animal health dedicated to innovating and delivering products designed to prevent and treat diseases in both farm and companion animals. For over 70 years, Elanco has helped improve the health of animal populations while creating a positive influence in both local and global communities. Guided by a vision of enriching lives through Food and Companionship, Elanco constantly strives to exceed expectations, underscoring its commitment to animal health.
For further inquiries:
- - Investor Contact: Tiffany Kanaga at (765) 740-0314 or email at tkanaga@elanco.com
- - Media Contact: Colleen Parr Dekker at (317) 989-7011 or email at cparrdekker@elanco.com